PHSI-BRG
PHSI-BRG
Home
Staff
Sarah Al Ashmori
Andy Bryant
Thomas Chadwick
Svetlana Cherlin
Mike Cole
Holly Fisher
Tony Fouweather
Shaun Hiu
Dorcas Kareithi
Ann Breeze Konkoth
Nan Lin
Jingky Lozano-Kuehne
Helen Mossop
Ellen Moss
Aritra Mukherjee
Jérémie Nsengimana
Vicky Ryan
Marzieh Shahmandi
Moha Shojaei
Dawn Teare
James Wason
Faye Williamson
Nina Wilson
Sylvia Zhang
PhD students
Ruqayya Azher
Nicole Cizauskas
Laura Etfer
Niamh Fitzgerald
Raiann Hamshaw
Pela Okorie
Samuel Sarkodie
Lou Whitehead
Methodology research
Overview
Adaptive designs
Master protocols
Transforming IMID trials
Projects
Publications
News
Courses
Adaptive Designs and Multiple Testing Procedures
Leveraging External Information
Precision Medicine Clinical Trials
Contact
Light
Dark
Automatic
Randomised controlled trial of granulocyte macrophage colony stimulating factor in critically ill patients with impaired neutrophil function
Pinder EM
,
Rostron AJ
,
Hellyer TP
,
Ruchaud-Sparagano M-H
,
Scott J
,
Macfarlane JG
,
Wiscombe S
,
Widdrington JD
,
Allen T
,
Roy AI
,
Linnett VC
,
Baudouin SV
,
Wright SE
,
Chadwick T
,
Fouweather A
,
Bowett S
,
Parker J
,
Corris PA
,
McAuley DF
,
Morris AC
,
Simpson AJ
January 2016
Type
Conference paper
Publication
American Journal of Respiratory and Critical Care Medicine
2016; 201:A2727
Chadwick
Fouweather
Related
Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study)
Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK)
Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial
Cite
×